Weighted Average Number of Shares Outstanding, Diluted of CV Sciences, Inc. from 31 Mar 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
CV Sciences, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2017 to 30 Sep 2025.
  • CV Sciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 184,264,000, a 1.1% increase year-over-year.
  • CV Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 175,585,000, a 14% increase from 2023.
  • CV Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 153,955,000, a 12% increase from 2022.
  • CV Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 138,034,000, a 28% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

CV Sciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 184,264,000 +2,003,000 +1.1% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 184,264,000 +11,846,000 +6.9% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 184,264,000 +21,189,000 +13% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 175,585,000 +21,630,000 +14% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 182,261,000 +27,657,000 +18% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 172,418,000 +19,819,000 +13% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 163,075,000 +10,971,000 +7.2% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 153,955,000 +15,921,000 +12% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 154,604,000 +8,074,000 +5.5% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 152,599,000 +17,185,000 +13% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 152,104,000 +35,270,000 +30% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 138,034,000 +30,217,000 +28% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 146,530,000 +37,415,000 +34% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 135,414,000 +27,791,000 +26% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 116,834,000 +12,326,000 +12% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 107,817,000 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 109,115,000 +9,165,000 +9.2% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 107,623,000 +7,760,000 +7.8% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 104,508,000 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 99,950,000 +1,217,000 +1.2% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 99,863,000 -21,066,000 -17% 01 Apr 2020 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q4 2019 97,861,000 -16,609,000 -15% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2020 2019 FY
Q3 2019 98,733,000 -17,156,000 -15% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 120,929,000 +8,463,000 +7.5% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 95,168,000 -468,000 -0.49% 01 Jan 2019 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 114,470,000 +34,038,000 +42% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 115,889,000 +27,774,396 +32% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 112,466,000 +29,606,910 +36% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 95,636,000 +35,537,352 +59% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 80,432,000 01 Oct 2017 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 88,114,604 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 82,859,090 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018 2018 Q2
Q1 2017 60,098,648 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1

CV Sciences, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 175,585,000 +21,630,000 +14% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 153,955,000 +15,921,000 +12% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 138,034,000 +30,217,000 +28% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 107,817,000 +7,904,000 +7.9% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 99,913,000 +2,052,000 +2.1% 01 Jan 2020 31 Dec 2020 10-K 04 Apr 2022 2021 FY
2019 97,861,000 -16,609,000 -15% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2020 2019 FY
2018 114,470,000 +34,038,000 +42% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 80,432,000 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.